Recent Talks on PAT Implementation
- Multi-Scale PAT for Small Molecule Development
Dr. Zachary Dance - Merck & Co., Inc.
- Automation at AbbVie: The Culture and Impact of Adopting New Technology
Westin Morrill - AbbVie
During this live stream, a technology and application expert will be online to answer your questions live.
If you are unable attend the live event, register to receive links to the on-demand presentations.
Dr. Zachary Dance – Merck
After receiving his Ph.D. in Physical Organic Chemistry from Northwestern University, Dr. Dance joined Merck’s Center for Materials Science and Engineering. Since then, he has developed expertise in solid state characterization and PAT in materials of pharmaceutical interest. Most recently, Dr. Dance has led the Merck Research Labs Small Molecule PAT team. He has experience supporting development at all scales, troubleshooting, process optimization, and experimental design related to synthetic reaction understanding and physicochemical properties of APIs and excipients, as well as contributing to multiple patent and regulatory filings.
Westin Morrill - Abbvie
Westin Morrill is a Process Chemist for AbbVie, in North Chicago, IL. He completed his undergraduate work at Portland State University under the guidance of Professor David Peyton in 2009. This lead to his work on development of anti-malarial drugs at DesignMedix, also in Portland. In 2013, he earned an industrial Master of Science in Chemistry from the University of Oregon while working at W.R. Grace developing large scale manufacturing conditions for organometallic complexes and nucleosides. In 2013, he started at the AbbVie Process Chemistry group. He has been a part of several programs, including the process development for Glecaprevir. In conjunction with Process Chemistry, he also helps lead the automation effort at AbbVie.